At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CTEV Claritev Corporation
Trading 10-02 12:08:32 EDT
22.27
+0.96
+4.50%
High22.28Low21.32Vol76.24K
Open21.92D1 Closing21.31Amplitude4.50%
Mkt Cap377.85MTradable Cap126.31MTotal Shares16.97M
T/O1.66MT/O Rate1.34%Tradable Shares5.67M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Claritev EVP, CFO Douglas Michael Garis Sells USD 276,009 of Common Shares
Reuters  ·  09-23
Claritev EVP, CFO Douglas Michael Garis Sells USD 276,009 of Common Shares
Claritev Selected by GDIT to Support CDC World Trade Center Health Program Provider Network
Reuters  ·  09-22
Claritev Selected by GDIT to Support CDC World Trade Center Health Program Provider Network
Claritev Corp - to Administer Nationwide Provider Network for Wtc Health Program
THOMSON REUTERS  ·  09-22
Claritev Corp - to Administer Nationwide Provider Network for Wtc Health Program
Claritev Corp - Selected by Gdit to Support World Trade Center Health Program
THOMSON REUTERS  ·  09-22
Claritev Corp - Selected by Gdit to Support World Trade Center Health Program
Claritev Announces Availability of 2025 Corporate Responsibility Report
Reuters  ·  09-17
Claritev Announces Availability of 2025 Corporate Responsibility Report
Claritev Files Form 3 as Director Thomas Benjamin Letham Reports no Beneficial Ownership
Reuters  ·  09-17
Claritev Files Form 3 as Director Thomas Benjamin Letham Reports no Beneficial Ownership
Claritev Targets Faster Solution Rollout with Technology Modernization, AI Readiness Push
Reuters  ·  09-16
Claritev Targets Faster Solution Rollout with Technology Modernization, AI Readiness Push
Claritev appoints Letham to its Board of Directors
TIPRANKS  ·  09-15
Claritev appoints Letham to its Board of Directors
Claritev Appoints Ben Letham to Its Board of Directors
THOMSON REUTERS  ·  09-15
Claritev Appoints Ben Letham to Its Board of Directors
Claritev Says Healthcare Pricing Intelligence Turns Transparency Data into Operational Cost-Management Tool
Reuters  ·  09-09
Claritev Says Healthcare Pricing Intelligence Turns Transparency Data into Operational Cost-Management Tool
Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares
Reuters  ·  08-31
Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares
Claritev Management to Present at Morgan Stanley Global Healthcare Conference
Reuters  ·  08-27
Claritev Management to Present at Morgan Stanley Global Healthcare Conference
U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions
Reuters  ·  08-21
U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions
Claritev price target raised to $40 from $28 at Barclays
TIPRANKS  ·  08-21
Claritev price target raised to $40 from $28 at Barclays
Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95
Reuters  ·  08-19
Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95
Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI
Reuters  ·  08-18
Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
THOMSON REUTERS  ·  08-17
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services
Reuters  ·  08-17
Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services
Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation
Reuters  ·  08-15
Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation
Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44
Reuters  ·  08-13
Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44

Introduction

Company Name.
Claritev Corporation
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, dental, government and property and casualty markets. For more information, visit multiplan.com.
Issue price:
--